バイオリアクターの世界市場レポート 2025年

バイオリアクター市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR14.9％で185億8,000万米ドルに成長します。予測期間中に予想される成長は、バイオテクノロジー研究への投資の増加、慢性疾患の有病率の上昇、ワクチンや治療用タンパク質の需要の増加、バイオ製造に対する規制支援の強化、先端療法の使用の増加などの要因によるものと考えられます。この期間の主要動向としては、バイオテクノロジーの進歩、自動化と制御システムの改善、バイオプロセス開発の成長、製造効率の向上、拡大可能な生産ソリューションに対するニーズの高まりなどが挙げられます。

バイオ医薬品に対する需要の高まりが、今後数年間のバイオリアクター市場の成長を牽引すると予想されます。バイオ医薬品は、タンパク質、細胞、生物などの生物由来の治療用製品であり、さまざまな疾患の予防、治療、管理に使用されます。このような需要の高まりは、医療研究の進歩、個別化医療の台頭、革新的な治療の必要性などに後押しされており、世界のヘルスケア成果の向上に貢献しています。バイオリアクターは、治療製品の効率的でスケーラブルな生産を可能にすることで、バイオ医薬品セクターにおいて重要な役割を果たしています。安定した品質を確保し、製造コストを下げ、生命を変える革新的な医薬品の開発をサポートします。例えば、2024年5月、米国の産業団体である米国研究製薬工業協会のデータによると、米国のバイオ医薬品産業は2022年に1兆6,500億米ドル以上の総生産高を上げ、その内訳は直接生産によるものが8,000億米ドル、サプライヤーや関連部門によるものがさらに8,000億米ドルで、米国経済の3.6％を占めることが明らかになりました。その結果、バイオ医薬品に対する需要の増加がバイオリアクター市場の成長を後押ししています。

バイオリアクター市場の主要企業は、より複雑な生物学的培養の成長に対応するため、固定床バイオリアクターなどの革新的なソリューションの創出に注力しています。固定床のバイオリアクターは、多くの場合ビーズ、繊維、顆粒などの多孔質材料で作られた固体支持構造を利用し、そこに生物体を付着させています。この設計により、物質移動が改善され、せん断応力が減少し、生物学的プロセスの制御が向上します。例えば、2024年10月、ベルギーに本社を置くバイオテクノロジー企業、Univercells Technologiesは、Scale-X Nexoバイオリアクターを発表しました。この先進的なバイオリアクターは、0.5m2の増殖表面を持ち、細胞培養プロセス開発を最適化するよう調整されており、バイオ製薬会社や研究機関に大きな利点をもたらします。Scale-X Nexoは、より大きなモデルへのシームレスなスケーラビリティを可能にし、培地や試薬の使用量を削減し、従来型エントリーレベルのバイオリアクターと比較して運用コストを最大60％削減することができます。さらに、Skaia Visionアプリケーションソフトウェアと統合し、直接サンプリングすることなく正確な細胞数を推定することで生産性を向上させます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のバイオリアクターPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバイオリアクター市場：成長率分析
• 世界のバイオリアクター市場の実績：規模と成長、2019～2024年
• 世界のバイオリアクター市場の予測：規模と成長、2024～2029年、2034年
• 世界のバイオリアクター総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオリアクター市場：バイオプロセスタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• バッチとフェドバッチ
• 常用
• 世界のバイオリアクター市場：細胞別、実績と予測、2019～2024年、2024～2029年、2034年
• 哺乳類細胞
• 細菌細胞
• 酵母細胞
• その他の細胞
• 世界のバイオリアクター市場：制御別、実績と予測、2019～2024年、2024～2029年、2034年
• 手動
• 自動
• 世界のバイオリアクター市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• ラボスケール生産
• パイロットスケール生産
• 本格生産
• 世界のバイオリアクター市場：最終用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 研究開発（R&D）組織
• バイオ医薬品（バイオファーマ）メーカー
• 契約製造組織（CMO）
• 世界のバイオリアクター市場、バッチ法とフェドバッチ法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 伝統的バッチバイオリアクター
• フェッドバッチバイオリアクター
• 世界のバイオリアクター市場、連続サブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 灌流バイオリアクター
• 常用撹拌タンクバイオリアクター（CSTR）

第7章 地域別・国別分析

• 世界のバイオリアクター市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のバイオリアクター市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオリアクター市場：競合情勢
• バイオリアクター市場：企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • GE HealthCare Technologies Inc.
  • Cytiva Bioscience Holding Ltd.

第31章 その他の大手企業と革新的企業

• Sartorius AG
• Cellexus Ltd.
• Getinge AB
• Eppendorf AG
• ZETA Holding
• Pierre Guerin
• Broadley-James Corporation
• PBS BIoTech Inc.
• TAP Biosystems
• Solida BIoTech GmBH
• BBI-BIoTech GmbH
• HiTec Zang GmbH
• Xiamen Ollital Technology Co. Ltd.
• Bioengineering AG
• Infors AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• バイオリアクター市場、2029年：新たな機会を提供する国
• バイオリアクター市場、2029年：新たな機会を提供するセグメント
• バイオリアクター市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

A bioreactor is a specialized system designed to maintain optimal conditions for biological processes, supporting the growth and function of cells, microorganisms, or enzymes. It ensures suitable environmental factors, including temperature, pH, oxygen, and nutrient supply, to enable desired biochemical reactions. Bioreactors are commonly utilized in industries such as pharmaceuticals, food production, and wastewater treatment.

The primary types of bioprocesses used in bioreactors are batch, fed-batch, and continuous. Bioreactors can support both batch and fed-batch processes, offering flexibility in optimizing production based on the complexity of the product and required yields. They are used with various cell types, including mammalian, bacterial, and yeast cells, and incorporate different control methods, such as manual and automated systems. Bioreactors are employed in applications ranging from lab-scale and pilot-scale production to full-scale production, serving end users such as research and development (R&D) organizations, biopharmaceutical manufacturers, and contract manufacturing organizations (CMOs).

The bioreactors market research report is one of a series of new reports from The Business Research Company that provides bioreactors market statistics, including the bioreactors industry global market size, regional shares, competitors with the bioreactors market share, detailed bioreactors market segments, market trends, and opportunities, and any further data you may need to thrive in the bioreactors industry. These bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioreactors market size has grown rapidly in recent years. It will grow from $9.22 billion in 2024 to $10.64 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be attributed to several factors, including the increasing demand for biopharmaceuticals, the rise in cell and gene therapy research, a growing focus on personalized medicine, the adoption of single-use bioreactor technology, and the need for more efficient manufacturing processes.

The bioreactors market size is expected to see rapid growth in the next few years. It will grow to $18.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth anticipated during the forecast period can be attributed to factors such as increased investment in biotechnology research, the rising prevalence of chronic diseases, growing demand for vaccines and therapeutic proteins, enhanced regulatory support for biomanufacturing, and the increasing use of advanced therapies. Key trends for this period include advancements in biotechnology, improvements in automation and control systems, growth in bioprocess development, enhancements in manufacturing efficiency, and a rising need for scalable production solutions.

The rising demand for biopharmaceuticals is anticipated to drive the growth of the bioreactors market in the coming years. Biopharmaceuticals are therapeutic products derived from biological sources, including proteins, cells, and living organisms, used to prevent, treat, or manage various diseases. This growing demand is fueled by advancements in medical research, the rise of personalized medicine, and the need for innovative treatments, which contribute to improved healthcare outcomes globally. Bioreactors play a crucial role in the biopharmaceutical sector by enabling the efficient and scalable production of therapeutic products. They ensure consistent quality, lower production costs, and support the development of innovative, life-changing medicines. For example, in May 2024, data from Pharmaceutical Research and Manufacturers of America, a U.S.-based trade association, revealed that the U.S. biopharmaceutical industry generated over $1.65 trillion in total output in 2022, including $800 billion from direct production and another $800 billion from suppliers and related sectors, representing 3.6% of the U.S. economy. Consequently, the increasing demand for biopharmaceuticals is fueling the growth of the bioreactors market.

Leading companies in the bioreactors market are focusing on creating innovative solutions, such as fixed-bed bioreactors, to accommodate the growth of more complex biological cultures. Fixed-bed bioreactors utilize a solid support structure, often made from porous materials such as beads, fibers, or granules, to which biological organisms adhere. This design improves mass transfer, reduces shear stress, and offers better control over biological processes. For example, in October 2024, Univercells Technologies, a biotechnology company based in Belgium, introduced the Scale-X Nexo bioreactor. This advanced bioreactor, with a 0.5 m2 growth surface, is tailored to optimize cell culture process development, delivering significant advantages for biopharmaceutical companies and research organizations. The Scale-X Nexo enables seamless scalability to larger models, reduces media and reagent usage, and can cut operational costs by up to 60% compared to conventional entry-level bioreactors. Furthermore, it integrates with Skaia Vision application software, enhancing productivity by providing accurate cell count estimates without requiring direct sampling.

In December 2022, MilliporeSigma, a U.S.-based life sciences organization, acquired Erbi Biosystems Inc. for an undisclosed sum. This acquisition aims to enhance MilliporeSigma's upstream portfolio for therapeutic proteins by incorporating Erbi Biosystems' advanced 2 ml micro-bioreactor technology. The integration supports scalable, automated perfusion cell culture processes and accelerates the creation of life-enhancing therapeutics. Erbi Biosystems Inc., a U.S.-based biotechnology firm, specializes in the development of micro-bioreactor systems for optimizing cell culture and bioprocesses.

Major players in the bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Cytiva Bioscience Holding Ltd., Sartorius AG, Cellexus Ltd., Getinge AB, Eppendorf AG, ZETA Holding, Pierre Guerin, Broadley-James Corporation, PBS Biotech Inc., TAP Biosystems, Solida Biotech GmBH, BBI-Biotech GmbH, HiTec Zang GmbH, Xiamen Ollital Technology Co. Ltd., Bioengineering AG, Infors AG, Univercells Technologies SA, CerCell A/S, Bailun Biotechnology Co. Ltd., BioNet, and Shanghai Ritai Medicine Equipment Project Co. Ltd.

North America was the largest region in the bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioreactors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioreactors market consists of sales of stirred-tank bioreactors (STRs), airlift bioreactors, bubble column bioreactors, and packed-bed bioreactors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioreactors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Bioprocess: Batch And Fed-Batch; Continuous
• 2) By Cell: Mammalian Cells; Bacterial Cells; Yeast Cells; Other Cells
• 3) By Control: Manual; Automated
• 4) By Usage: Lab Scale Production; Pilot Scale Production; Full Scale Production
• 5) By End-Use: Research And Development (R&D) Organizations; Biopharmaceutical (Biopharma) Manufacturers; Contract Manufacturing Organizations (CMOS)
• Subsegments:
• 1) By Batch And Fed-Batch: Traditional Batch Bioreactors; Fed-Batch Bioreactors
• 2) By Continuous: Perfusion Bioreactors; Continuous Stirred Tank Bioreactors (CSTR)
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Cytiva Bioscience Holding Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioreactors Market Characteristics

3. Bioreactors Market Trends And Strategies

4. Bioreactors Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bioreactors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioreactors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioreactors Market Growth Rate Analysis
• 5.4. Global Bioreactors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioreactors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioreactors Total Addressable Market (TAM)

6. Bioreactors Market Segmentation

• 6.1. Global Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Batch And Fed-Batch
• Continuous
• 6.2. Global Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammalian Cells
• Bacterial Cells
• Yeast Cells
• Other Cells
• 6.3. Global Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual
• Automated
• 6.4. Global Bioreactors Market, Segmentation By Usage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lab Scale Production
• Pilot Scale Production
• Full Scale Production
• 6.5. Global Bioreactors Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research And Development (R&D) Organizations
• Biopharmaceutical (Biopharma) Manufacturers
• Contract Manufacturing Organizations (CMOs)
• 6.6. Global Bioreactors Market, Sub-Segmentation Of Batch And Fed-Batch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Batch Bioreactors
• Fed-Batch Bioreactors
• 6.7. Global Bioreactors Market, Sub-Segmentation Of Continuous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perfusion Bioreactors
• Continuous Stirred Tank Bioreactors (CSTR)

7. Bioreactors Market Regional And Country Analysis

• 7.1. Global Bioreactors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioreactors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioreactors Market

• 8.1. Asia-Pacific Bioreactors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioreactors Market

• 9.1. China Bioreactors Market Overview
• 9.2. China Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioreactors Market

• 10.1. India Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioreactors Market

• 11.1. Japan Bioreactors Market Overview
• 11.2. Japan Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioreactors Market

• 12.1. Australia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioreactors Market

• 13.1. Indonesia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioreactors Market

• 14.1. South Korea Bioreactors Market Overview
• 14.2. South Korea Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioreactors Market

• 15.1. Western Europe Bioreactors Market Overview
• 15.2. Western Europe Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioreactors Market

• 16.1. UK Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioreactors Market

• 17.1. Germany Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioreactors Market

• 18.1. France Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioreactors Market

• 19.1. Italy Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioreactors Market

• 20.1. Spain Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioreactors Market

• 21.1. Eastern Europe Bioreactors Market Overview
• 21.2. Eastern Europe Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioreactors Market

• 22.1. Russia Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioreactors Market

• 23.1. North America Bioreactors Market Overview
• 23.2. North America Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioreactors Market

• 24.1. USA Bioreactors Market Overview
• 24.2. USA Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioreactors Market

• 25.1. Canada Bioreactors Market Overview
• 25.2. Canada Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioreactors Market

• 26.1. South America Bioreactors Market Overview
• 26.2. South America Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioreactors Market

• 27.1. Brazil Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioreactors Market

• 28.1. Middle East Bioreactors Market Overview
• 28.2. Middle East Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioreactors Market

• 29.1. Africa Bioreactors Market Overview
• 29.2. Africa Bioreactors Market, Segmentation By Type Of Bioprocess, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioreactors Market, Segmentation By Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioreactors Market, Segmentation By Control, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioreactors Market Competitive Landscape And Company Profiles

• 30.1. Bioreactors Market Competitive Landscape
• 30.2. Bioreactors Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cytiva Bioscience Holding Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Bioreactors Market Other Major And Innovative Companies

• 31.1. Sartorius AG
• 31.2. Cellexus Ltd.
• 31.3. Getinge AB
• 31.4. Eppendorf AG
• 31.5. ZETA Holding
• 31.6. Pierre Guerin
• 31.7. Broadley-James Corporation
• 31.8. PBS Biotech Inc.
• 31.9. TAP Biosystems
• 31.10. Solida Biotech GmBH
• 31.11. BBI-Biotech GmbH
• 31.12. HiTec Zang GmbH
• 31.13. Xiamen Ollital Technology Co. Ltd.
• 31.14. Bioengineering AG
• 31.15. Infors AG

32. Global Bioreactors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioreactors Market

34. Recent Developments In The Bioreactors Market

35. Bioreactors Market High Potential Countries, Segments and Strategies

• 35.1 Bioreactors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioreactors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioreactors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer